Cite
HARVARD Citation
Ye, J. et al. (2019). Adjunct ketamine treatment effects on treatment-resistant depressive symptoms in chronic treatment-resistant schizophrenia patients are short-term and disassociated from regional homogeneity changes in key brain regions – a pilot study. Psychiatry and clinical psychopharmacology. 29 (4), pp. 907-915. [Online].